Research team: Montse Ferrer (IP), Garin O, Pardo Y, Martínez A, Urreta I, Hervás A, Francés A.
Methods: Multicenter observational study of a prospective inception cohort of patients diagnosed with bladder cancer (n= 900) and prostate cancer (n=600). Consecutive patients with an anatomopathologically confirmed diagnosis of bladder or prostate cancer (between 1/04/2010 and 31/03/2011) will be identified in 7 Spanish hospitals (5 regions). Their data will be collected in a database designed specifically for the project, which will include all the information about the onset of symptoms, the clinical process, diagnosis and therapy. HRQL assessments will be conducted before treatment, at 6 and 15-24 months after treatment.
These assessments will include: the generic questionnaires SF-36 and EQ-5D, which will permit to compare results with the Spanish reference standards; a generic questionnaire for patients with cancer, either FACT-G or EORTC-QLQ-C30, and a specific.
Key Words: Quality of life, prostate cancer, bladder cancer, urologic cancer, health services, outcomes
Funding: FONDO DE INVESTIGACIÓN SANITARIA. ISCIII. PS09/02139